AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2014
Nov 12, 2014
34301_dirs_2014-11-12_749d900f-5805-448a-be56-ad06d74e6468.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2014-11-11
Reporting Person: Girao Tiago (VP & Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-11 | Common Stock | P | 15889 | $0.39 | Acquired | 15889 | Direct |
| 2014-11-12 | Common Stock | P | 44111 | $0.39 | Acquired | 60000 | Direct |
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26